Christopher Rhyne, MD

Headache Medicine Specialist
Norton Neuroscience Institute

Poster(s):

• 1340 - The impact of onabotulinumtoxinA on oral pain medication use and low-value care in patients with cervical dystonia
  Friday, February 20, 2026

  5:00 PM - 6:30 PM AST